WYFODIC-B

WYFODIC-B Cream is a specialized dermatological formulation designed to address complex skin conditions that involve both bacterial infection and inflammation. Produced under the Arozia Care brand, this 10g cream combines potent active ingredients to provide a dual-action therapeutic approach, ensuring both the elimination of pathogens and the relief of physical discomfort such as redness, itching, and swelling.

Composition and Active Ingredients

The efficacy of WYFODIC-B lies in its precisely balanced composition:

• Fusidic Acid (2.0% w/w): This is a powerful antibacterial agent. Unlike many other antibiotics, Fusidic Acid is highly effective at penetrating intact skin. It works by inhibiting bacterial protein synthesis, specifically targeting Staphylococcus aureus, which is the primary culprit behind most skin infections like impetigo, infected eczema, and folliculitis.

• Beclomethasone Dipropionate (0.025% w/w): This is a potent corticosteroid. Its primary role is to suppress the body’s inflammatory response. When the skin is infected or irritated, it becomes red and swollen; Beclomethasone works at the cellular level to reduce the release of inflammatory substances, providing rapid relief from itching and burning sensations.

• Chlorocresol (0.1% w/w): Included as a preservative, this ensures the cream remains sterile and effective throughout its shelf life by preventing microbial growth within the tube.

Therapeutic Indications

WYFODIC-B is primarily indicated for “infected dermatoses.” This refers to inflammatory skin conditions where a secondary bacterial infection is either present or likely to occur. Common use cases include:

1. Infected Eczema/Dermatitis: Where the skin is cracked or scratched, allowing bacteria to enter.

2. Psoriasis with Secondary Infection: Helping to manage the thick scales of psoriasis while treating underlying microbial issues.

3. Contact Dermatitis: Inflammation caused by allergens or irritants that has become infected.

4. Impetigo: A highly contagious skin infection characterized by red sores.

Mechanism of Action

The synergy between the antibiotic and the steroid is what makes WYFODIC-B a comprehensive solution. While the Fusidic Acid aggressively targets the bacteria to stop the infection from spreading, the Beclomethasone Dipropionate calms the skin’s immune overreaction. This “two-pronged” attack not only heals the underlying cause but also significantly improves the patient’s quality of life by stopping the urge to scratch, which often leads to further skin damage and reinfection.

Quality Assurance and Standards

As highlighted by the product packaging, WYFODIC-B is manufactured under rigorous international quality standards. It carries certifications for WHO-GMP (World Health Organization – Good Manufacturing Practices) and ISO, ensuring that the product is consistently produced and controlled according to quality standards appropriate for its intended use.